Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline vs Levofloxacin for Acute COPD Exacerbation
NCT06915688Not yet recruiting
- Start
- Apr 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in chronic obstructive pulmonary disease (COPD) comparing Doxycycline with Levofloxacin (2 arms). Primary endpoint: Clinical Cure Rate at 7 days. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
doxycyclinelevofloxacin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06915688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06915688.